Billing code
G513A — Pentagastrin Stimulation For Calcitonin
Pentagastrin calcitonin test
Bill G513 for a pentagastrin stimulation test for calcitonin; it is payable in addition to a consultation or assessment.
Watch for: Add G700 only when the test is the sole reason for the visit; G700 is not payable in hospital.
| Provider | Specialist | Assistant | Anaesthetist | Non-anaesthetist |
|---|---|---|---|---|
| $42.30 | $0.00 | $0.00 | $0.00 | $0.00 |
- Code
- G513A
- Description
- Pentagastrin Stimulation For Calcitonin
- FHO+ basket
- Not in the FHO+ base rate basket (Schedule 2 or 2B).
- Effective date
- Apr 1, 2025
- Termination date
- No end date
Explanation
Updated October 26, 2026
Pentagastrin stimulation test for calcitonin.
What it covers
G513 is pentagastrin stimulation for calcitonin (J43).
Billing rules
- Payable in addition to a consultation or assessment unless listed as included (J3).
- Includes preparing the patient, doing the test with monitoring afterwards, interpreting results with a written report to the referring provider where appropriate, and follow-up arrangements (J3).
- Marked (+): when the test is the sole reason for the visit, add G700 once per visit. G700 is not payable in hospital, and not when you are also paid a consultation or assessment that day and have a financial interest in the facility (J3).
- For a patient enrolled with a capitation-based group, G700 pays 15% of its fee (J3).
Often billed with
- G700 basic fee-per-visit premium when the test is the only reason for the visit, outside hospital (J3).
Related codes: G501, G493, G344, G700
Source: Schedule of Benefits (July 1, 2026), Diagnostic and Therapeutic Procedures, Endocrinology and Metabolism, page J43; preamble J3.
APEX checks every paid claim against the Schedule of Benefits and flags codes billed below what the visit qualified for. See how APEX works · Pricing